2017
DOI: 10.1186/s13104-017-2636-3
|View full text |Cite
|
Sign up to set email alerts
|

Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy

Abstract: BackgroundAccumulating evidence indicate that circulating microRNAs (miRNAs) are useful independent non-invasive biomarkers, with unique miRNA signatures defined for various pathophysiological conditions. However, there are no established universal housekeeping miRNAs for the normalisation of miRNAs in body fluids. We have previously identified an oestrogen-responsive miRNA, miR-494, in regulating the anticoagulant, Protein S, in HuH-7 liver cells. Moreover, increased thrombotic risk associated with elevated c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
26
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(27 citation statements)
references
References 70 publications
1
26
0
Order By: Relevance
“…Of particular interest were CXCL13, BTLA, IL7R, LAMP3, and LTB as these genes have been linked to the presence of tertiary lymphoid structures (TLS) and high endothelial venules (HEV) within tumors. TIF miR-146a and miR-494, the most interconnected and co-abundant miRNAs in this cluster, were both previously annotated as negative regulators of immune-stimulatory genes and were DE in the plasma from patients with BC [158,192]. As tumor immune cell infiltration is highly related to patient prognosis [2], we propose genes and miRNA from this module to be candidate markers of tumor immune status, prognosis, and potentially patient response to immunotherapy.…”
Section: Resultsmentioning
confidence: 85%
“…Of particular interest were CXCL13, BTLA, IL7R, LAMP3, and LTB as these genes have been linked to the presence of tertiary lymphoid structures (TLS) and high endothelial venules (HEV) within tumors. TIF miR-146a and miR-494, the most interconnected and co-abundant miRNAs in this cluster, were both previously annotated as negative regulators of immune-stimulatory genes and were DE in the plasma from patients with BC [158,192]. As tumor immune cell infiltration is highly related to patient prognosis [2], we propose genes and miRNA from this module to be candidate markers of tumor immune status, prognosis, and potentially patient response to immunotherapy.…”
Section: Resultsmentioning
confidence: 85%
“…In the case of plasma samples, cells can be inadvertently aspirated during collection. The large differences observed using Nanostring are distinct from those reported using RT-PCR for detection of miRNA in a limited sample set [ 14 ]. A potential explanation for this could be that differences in the amount of very low abundant transcripts may not have been adequately detected by PCR, but were identified using Nanostring which does not rely on amplification of circulating transcripts.…”
Section: Discussionmentioning
confidence: 89%
“…miR-33a-5p (478347_mir GTGCATTGTAGTTGCATTGCA, ThermoFisher Scientific, Waltham, USA) was detected by the TaqMan 1 Advanced miRNA Assays (A25576, ThermoFisher Scientific, Waltham, USA) in liver. The spike miR-39-3p (C. elegans) [56] (478293_mir TCACCGGG TGTAAATCAGCTTG, ThermoFisher Scientific, Waltham, USA) was used for miR-33a normalization and it was present at relatively constant levels among the treatments. Total RNA in liver was obtained in the same way as that for gene expression analysis.…”
Section: Mirna Expression Analysis In Liver Hepatocytes and Plasmamentioning
confidence: 99%